Skip to main content

Advertisement

Table 7 Multivariate analysis of triple negative breast cancer survival

From: Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies

Included parameters Disease-free survival Overall survival
Hazard ratio 95 % CI p value Hazard ratio 95 % CI p value
Histologic grade    0.560    0.204
 I/II versus III 0.725 0.246–2.136   0.537 0.206–1.402  
T stage    0.027    0.016
 T1 versus T2/T3 10.21 1.306–79.90   6.317 1.413–28.23  
Lymph node metastasis    0.019    0.013
 No versus Yes 3.918 1.254–12.24   3.564 1.304–9.740  
Ki-67 LI    0.327    0.711
 ≤14 versus >14 0.581 0.197–1.719   1.209 0.443–3.298  
Stromal type    0.988    0.699
 Desmoplastic/sclerotic versus inflammatory 0.990 0.266–19.15   1.287 0.359–4.613  
PD-L1 (28-8) (I)    0.081    0.036
 Negative versus positive 4.019 0.843–19.15   5.112 1.110–23.54  
  1. Italics represents p < 0.05
  2. I immune cell